七味白術(shù)散治療兒童脾虛濕盛型腹瀉的療效評(píng)價(jià)研究
本文關(guān)鍵詞: 腹瀉病 脾虛濕盛型 七味白術(shù)散 出處:《北京中醫(yī)藥大學(xué)》2016年碩士論文 論文類型:學(xué)位論文
【摘要】:背景:兒童腹瀉病是由多種病因引起的以大便次數(shù)增多與大便性狀改變?yōu)橹饕Y狀的疾病,是嬰幼兒時(shí)期最常見的疾病之一,發(fā)病率在我國(guó)排第二位。根據(jù)世界衛(wèi)生組織(WHO)2009年的報(bào)告,每年共有150萬(wàn)兒童死于腹瀉病,在世界范圍內(nèi)也是導(dǎo)致兒童死亡的一大病因。急性腹瀉可出現(xiàn)脫水及電解質(zhì)紊亂,持續(xù)腹瀉可導(dǎo)致消化功能障礙、營(yíng)養(yǎng)不良、生長(zhǎng)發(fā)育落后等。按病程分類,可將兒童腹瀉病分為急性腹瀉、遷延性腹瀉和慢性腹瀉;依照病因,可分為感染性腹瀉和非感染性腹瀉,由于病原體不同,又可將感染性腹瀉分為細(xì)菌感染、病毒感染等。中醫(yī)將該病歸為“泄瀉”范疇,由于小兒脾常不足,感受外邪或內(nèi)傷飲食都易致病。在兒科臨床診療中發(fā)現(xiàn),根據(jù)病因給予中醫(yī)辨證論治療效頗佳,尤其對(duì)于兒童常見的脾虛濕盛型腹瀉,中醫(yī)辨證論治不但藥效價(jià)廉,而且對(duì)于相關(guān)證候的改善效果明顯。綜合大量文獻(xiàn)發(fā)現(xiàn),七味白術(shù)散治療兒童腹瀉病的療效顯著,并優(yōu)于腸黏膜保護(hù)劑等部分西藥,而以微生態(tài)調(diào)節(jié)劑作對(duì)比的研究尚待探索。目的:本研究以七味白術(shù)散為方,治療兒童脾虛濕盛型腹瀉,并與西藥雙歧桿菌四聯(lián)活菌片作對(duì)照,對(duì)其治療前后的證候進(jìn)行觀察,初步探索七味白術(shù)散湯劑治療兒童脾虛濕盛型腹瀉的優(yōu)勢(shì)所在。方法:本課題為前瞻性研究,研究對(duì)象為68例,為2014年6月——2015年9月期間在石景山區(qū)中醫(yī)醫(yī)院兒科門診就診并診斷為脾虛濕盛型腹瀉的患兒,應(yīng)用SPSS17.0軟件隨機(jī)分為治療組和對(duì)照組各34例,兩組均予飲食指導(dǎo)。治療組予口服七味白術(shù)散湯劑,每日1/3-1劑,對(duì)照組予口服雙歧桿菌四聯(lián)活菌片1-3片,每日3次。觀察患兒治療前后的證候并評(píng)分。所有資料均采用SPSS17.0進(jìn)行分析,所有計(jì)量資料治療組、對(duì)照組治療前后比較采用配對(duì)t檢驗(yàn),組間比較采用獨(dú)立樣本t檢驗(yàn),計(jì)數(shù)資料采用卡方檢驗(yàn),等級(jí)資料采用秩和檢驗(yàn)。結(jié)果:1.兩組療效比較:治療組、對(duì)照組的總有效率分別為94.1%和91.2%。兩組總有效率差異無(wú)統(tǒng)計(jì)學(xué)意義(卡方值=0.216,P=0.6420.05);兩組顯效率差異有統(tǒng)計(jì)學(xué)意義(卡方值=0.965,P=0.0150.05)。2.治療組治療前后證候評(píng)分比較:在大便次數(shù)、大便性狀、腹瀉病程、腹痛、嘔吐、精神、口渴、飲食、小便、面色、肛門各項(xiàng)評(píng)分存在差異,有統(tǒng)計(jì)學(xué)意義(P0.05)。3.兩組治療后第3天證候評(píng)分比較:治療組、對(duì)照組治療后第3天腹痛、口渴、飲食、面色各項(xiàng)評(píng)分存在差異,有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:1.七味白術(shù)散治療兒童脾虛濕盛型腹瀉療效可靠。2.治療組在部分相關(guān)證候改善方面優(yōu)于對(duì)照組。
[Abstract]:Background: diarrhoeal disease in children is one of the most common diseases in infantile age, which is mainly characterized by the increase of defecation frequency and the change of defecation character. According to the 2009 report of the World Health Organization (WHO), 1.5 million children die from diarrhoeal diseases every year, which is also a major cause of death in the world. Acute diarrhea can lead to dehydration and electrolyte disorders. Persistent diarrhea can lead to dyspepsia, malnutrition, stunted growth, etc. According to the course of disease, children's diarrhoeal diseases can be divided into acute diarrhea, persistent diarrhea and chronic diarrhea; according to the etiology, It can be divided into infectious diarrhea and non-infectious diarrhea. Because of the different pathogens, infectious diarrhea can also be divided into bacterial infection, viral infection and so on. In clinical diagnosis and treatment of pediatrics, it was found that it was very effective to treat TCM with syndrome differentiation according to the etiology, especially for the common diarrhea of spleen deficiency and dampness, and the differentiation of symptoms and signs of TCM was not only effective, but also cheap. It was found that Qiwei Baizhu Powder had a remarkable effect on treating diarrhea in children, and was superior to some western medicine such as intestinal mucosal protectant. Objective: in this study, Qiwei Baizhu Powder was used as the prescription to treat the diarrhea of children with spleen deficiency and dampness, and compared with the western medicine Bifidobacterium tetralogicum tablets, the syndromes before and after treatment were observed. Objective: to explore the advantages of Qiwei Baizhu decoction in treating diarrhea with spleen deficiency and dampness in children. From June 2014 to September 2015, children with diarrhea of spleen deficiency and dampness were randomly divided into treatment group (34 cases) and control group (34 cases). The treatment group was given 1 / 3-1 dose of Qiwei Baizhu decoction daily, while the control group was given 1-3 tablets of bifidobacterium tetralogens. All the data were analyzed by SPSS17.0. All the metrological data in treatment group and control group were matched t test before and after treatment, and independent sample t test was used for comparison between groups. The counting data were chi-square test and rank data were rank sum test. Results the curative effect of the two groups was compared: treatment group, The total effective rate of the control group was 94.1% and 91.2, respectively. There was no significant difference in the total effective rate between the two groups (chi-square value was 0.216p, P < 0.6420.05), and the difference between the two groups was statistically significant (chi-square value was 0.965p 0.0150.05n.2.) before and after treatment, the scores of syndromes in the treatment group were as follows: the number of defecation times, the defecation traits, the difference between the two groups were statistically significant. The course of diarrhea, abdominal pain, vomiting, spirit, thirst, diet, urination, facial color, anus scores were different, there were significant differences between the two groups after treatment on the third day after the treatment of syndrome score comparison: treatment group, control group 3 days after treatment abdominal pain, There were significant differences in the scores of thirst, diet and facial color. Conclusion: 1. Qiwei Baizhu Powder is effective and reliable in treating diarrhea of children with spleen deficiency and dampness. 2. The treatment group is superior to the control group in improving some related syndromes.
【學(xué)位授予單位】:北京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2016
【分類號(hào)】:R272
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 ;白術(shù)散[J];光明中醫(yī);2013年03期
2 王原;余亮科;韓秀紅;袁麗艷;崔穎;馬寧;;七味白術(shù)散治療抗生素相關(guān)性腹瀉療效觀察[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2013年10期
3 朱先康;七味白術(shù)散治療小兒腹瀉98例療效觀察[J];江蘇中醫(yī);1996年05期
4 徐俊;七味白術(shù)散加減治療慢性非特異性潰瘍性結(jié)腸炎48例[J];安徽中醫(yī)臨床雜志;1998年05期
5 李天偉,梅明;七味白術(shù)散淺談[J];河北中醫(yī);2001年06期
6 張忠富;七味白術(shù)散運(yùn)用心得[J];中國(guó)社區(qū)醫(yī)師;2002年01期
7 張慎泰;張振尊;;七味白術(shù)散治療小兒腹瀉67例[J];中醫(yī)兒科雜志;2007年06期
8 劉杰;;七味白術(shù)散治療小兒腹瀉芻議[J];江西中醫(yī)藥;2008年07期
9 楊迪軼;;健脾白術(shù)散治療小兒腹瀉78例[J];中國(guó)中醫(yī)急癥;2010年10期
10 陳丹;陳文利;;七味白術(shù)散治療小兒腹瀉研究概況[J];遼寧中醫(yī)藥大學(xué)學(xué)報(bào);2012年03期
相關(guān)會(huì)議論文 前4條
1 王建敏;;試論七味白術(shù)散[A];第28次全國(guó)中醫(yī)兒科學(xué)術(shù)大會(huì)暨2011年名老中醫(yī)治療(兒科)疑難病臨床經(jīng)驗(yàn)高級(jí)專修班論文匯編[C];2011年
2 方建佳;;七味白術(shù)散治療功能性消化不良32例臨床觀察[A];第二十一屆全國(guó)中西醫(yī)結(jié)合消化系統(tǒng)疾病學(xué)術(shù)會(huì)議暨國(guó)家級(jí)中西醫(yī)結(jié)合消化系統(tǒng)疾病新進(jìn)展學(xué)習(xí)班論文匯編[C];2009年
3 鄭家遠(yuǎn);;加減“七味白術(shù)散”治療小兒脾虛腹瀉60例臨床觀察[A];劉弼臣教授從醫(yī)六十五周年學(xué)術(shù)思想研討會(huì)暨中華中醫(yī)藥學(xué)會(huì)兒科分會(huì)與全國(guó)中醫(yī)藥高等教育學(xué)會(huì)兒科分會(huì)全國(guó)學(xué)術(shù)交流大會(huì)論文匯編[C];2004年
4 沈秀鳳;;中藥配合推拿治療小兒抗生素相關(guān)性腹瀉38例[A];第28次全國(guó)中醫(yī)兒科學(xué)術(shù)大會(huì)暨2011年名老中醫(yī)治療(兒科)疑難病臨床經(jīng)驗(yàn)高級(jí)專修班論文匯編[C];2011年
相關(guān)重要報(bào)紙文章 前2條
1 四川自貢自流井區(qū)怡康中醫(yī)診所 王昆文;鄒潤(rùn)安論白術(shù)[N];中國(guó)中醫(yī)藥報(bào);2008年
2 霍雨冬;補(bǔ)脾益氣用白術(shù)[N];醫(yī)藥養(yǎng)生保健報(bào);2006年
相關(guān)博士學(xué)位論文 前3條
1 李文革;超微七味白術(shù)散對(duì)菌群失調(diào)腹瀉小鼠腸道微生物的影響研究[D];湖南農(nóng)業(yè)大學(xué);2014年
2 孫必強(qiáng);七味白術(shù)散對(duì)HRV感染機(jī)體TLR3信號(hào)轉(zhuǎn)導(dǎo)通路中相關(guān)元件表達(dá)的影響[D];湖南中醫(yī)藥大學(xué);2016年
3 白巖;浙江白術(shù)生產(chǎn)現(xiàn)狀和優(yōu)化農(nóng)藝措施研究[D];河北農(nóng)業(yè)大學(xué);2009年
相關(guān)碩士學(xué)位論文 前10條
1 鄧婷;自擬白術(shù)散治療新生兒抗生素相關(guān)性腹瀉(脾虛證)的臨床觀察[D];湖南中醫(yī)藥大學(xué);2016年
2 趙岳;七味白術(shù)散治療兒童脾虛濕盛型腹瀉的療效評(píng)價(jià)研究[D];北京中醫(yī)藥大學(xué);2016年
3 彭昕欣;蔗糖對(duì)七味白術(shù)散治療菌群失調(diào)腹瀉小鼠腸道微生物及酶的影響[D];湖南中醫(yī)藥大學(xué);2015年
4 吳海;超微七味白術(shù)散對(duì)腸道微生物分子多樣性的影響[D];湖南中醫(yī)藥大學(xué);2012年
5 葉俏波;影響白術(shù)在復(fù)方中功效發(fā)揮方向的相關(guān)因素研究[D];成都中醫(yī)藥大學(xué);2004年
6 張華玲;超微七味白術(shù)散對(duì)腸道微生物代謝多樣性的影響[D];湖南中醫(yī)藥大學(xué);2013年
7 王歡;七味白術(shù)散與酵母菌聯(lián)用對(duì)菌群失調(diào)腹瀉小鼠腸道菌群分子多樣性的影響[D];湖南中醫(yī)藥大學(xué);2015年
8 陳文;白術(shù)有效成分的研究[D];湖南師范大學(xué);2007年
9 郭抗蕭;超微七味白術(shù)散與酵母菌配伍治療菌群失調(diào)腹瀉的研究[D];湖南中醫(yī)藥大學(xué);2014年
10 何承殷;白術(shù)在《臨證指南醫(yī)案》中應(yīng)用的研究[D];廣州中醫(yī)藥大學(xué);2013年
,本文編號(hào):1509188
本文鏈接:http://sikaile.net/zhongyixuelunwen/1509188.html